论文部分内容阅读
目前尚无多西他赛与长春瑞滨治疗早期乳腺癌效果的比较。HER-2阳性患者给予化疗联合短期曲妥珠单克隆抗体辅助治疗的疗效和长期安全性也尚属未知。Joensuu在2009年27卷34期的《Journal of Clinical Oncology》杂志上以“Fluorouracil,Epirubicin,and Cyclophosphamide With Eit
There is currently no comparison of the efficacy of docetaxel and vinorelbine in the treatment of early-stage breast cancer. The efficacy and long-term safety of adjuvant chemotherapy with HER-2 plus short-term trastuzumab in HER-2-positive patients are unknown. Joensuu, “Journal of Clinical Oncology,” Volume 27, Issue 27, 2009, "Fluorouracil, Epirubicin, and Cyclophosphamide With Eit